Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for benign breast tumor
IRCT20100209003320N24Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vitamin d in benign breast conditions (BBD), sponsored by Tabriz University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
vitamin d
03
Conditions
benign breast conditions (BBD)
Beyond the preview
Go deeper on IRCT20100209003320N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100209003320N24.